• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清矿物质浓度与路德维希港风险和心血管健康研究中肾功能相关死亡率的相关性。

Associations between serum mineral concentrations and mortality by renal function in the Ludwigshafen Risk and Cardiovascular Health Study.

机构信息

Institute of Nutritional Sciences, Friedrich Schiller University Jena, Dornburger Straße 25, 07743, Jena, Germany.

Competence Cluster for Nutrition and Cardiovascular Health (nutriCARD) Halle-Jena-Leipzig, Jena, Germany.

出版信息

Sci Rep. 2024 Nov 19;14(1):28581. doi: 10.1038/s41598-024-79575-w.

DOI:10.1038/s41598-024-79575-w
PMID:39562674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11577029/
Abstract

The association of serum concentrations of minerals and phosphate with overall and cardiovascular mortality based on renal function is poorly understood. 3307 patients (average age 62.7 ± 10.6 years) in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study were grouped by estimated glomerular filtration rate (eGFR) into three categories: < 60, 60-89, and ≥ 90 mL/min per 1.73 m, per KDIGO 2022 guidelines and were analysed using Cox regression. Low serum sodium and iron concentrations were associated with poor renal function and increased overall mortality risk, whereas higher serum zinc concentrations were associated with reduced overall and cardiovascular mortality risk. Elevated serum copper concentrations were associated with increased mortality risk across all eGFR categories. Comparing low and normal eGFR, we observed a fourfold increase in all-cause mortality risk for eGFR < 60 mL/min per 1.73 m and a twofold increase for eGFR 60-89 mL/min per 1.73 m, accompanied by changes in serum mineral concentrations. The optimal range of mineral and phosphate concentrations in serum was strongly related to renal function. To reduce mortality risk, it's important to regularly monitor serum mineral and phosphate concentrations as well as renal function, especially in cardiovascular patients with compromised renal function.

摘要

基于肾功能,血清矿物质和磷酸盐浓度与全因和心血管死亡率的相关性尚未得到充分了解。3307 名(平均年龄 62.7±10.6 岁)来自路德维希港风险和心血管健康(LURIC)研究的患者,根据估算肾小球滤过率(eGFR)分为三组:<60、60-89 和≥90 mL/min per 1.73 m2,按照 KDIGO 2022 指南进行分组,并使用 Cox 回归进行分析。血清钠和铁浓度低与肾功能差和全因死亡率增加相关,而血清锌浓度高与全因和心血管死亡率降低相关。血清铜浓度升高与所有 eGFR 类别中的死亡率风险增加相关。与低 eGFR 和正常 eGFR 相比,我们观察到 eGFR<60 mL/min per 1.73 m2 的全因死亡率风险增加了四倍,eGFR 60-89 mL/min per 1.73 m2 的全因死亡率风险增加了两倍,同时伴有血清矿物质浓度的变化。血清矿物质和磷酸盐浓度的最佳范围与肾功能密切相关。为了降低死亡率风险,定期监测血清矿物质和磷酸盐浓度以及肾功能非常重要,尤其是在肾功能受损的心血管病患者中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1904/11577029/4c32897f50fe/41598_2024_79575_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1904/11577029/f327fa52ff08/41598_2024_79575_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1904/11577029/4c32897f50fe/41598_2024_79575_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1904/11577029/f327fa52ff08/41598_2024_79575_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1904/11577029/4c32897f50fe/41598_2024_79575_Fig2_HTML.jpg

相似文献

1
Associations between serum mineral concentrations and mortality by renal function in the Ludwigshafen Risk and Cardiovascular Health Study.血清矿物质浓度与路德维希港风险和心血管健康研究中肾功能相关死亡率的相关性。
Sci Rep. 2024 Nov 19;14(1):28581. doi: 10.1038/s41598-024-79575-w.
2
Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies.半乳糖凝集素-3、肾功能与临床结局:来自LURIC和4D研究的结果
J Am Soc Nephrol. 2015 Sep;26(9):2213-21. doi: 10.1681/ASN.2014010093. Epub 2015 Jan 7.
3
Copeptin Associates with Cause-Specific Mortality in Patients with Impaired Renal Function: Results from the LURIC and the 4D Study.copeptin与肾功能受损患者的特定病因死亡率相关:LURIC和4D研究结果
Clin Chem. 2017 May;63(5):997-1007. doi: 10.1373/clinchem.2016.266254. Epub 2017 Mar 9.
4
Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.成纤维细胞生长因子23(FGF23)与死亡率:路德维希港风险与心血管健康研究
Atherosclerosis. 2014 Nov;237(1):53-9. doi: 10.1016/j.atherosclerosis.2014.08.037. Epub 2014 Aug 28.
5
Association of plasma aldosterone with cardiovascular mortality in patients with low estimated GFR: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study.血浆醛固酮与低估计肾小球滤过率患者心血管死亡率的关系:路德维希港风险和心血管健康 (LURIC) 研究。
Am J Kidney Dis. 2011 Mar;57(3):403-14. doi: 10.1053/j.ajkd.2010.10.047. Epub 2010 Dec 24.
6
Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.成纤维细胞生长因子 23 及其标志物与肾功能正常个体的矿物质代谢。
Kidney Int. 2016 Sep;90(3):648-57. doi: 10.1016/j.kint.2016.04.024. Epub 2016 Jun 28.
7
Association between renal function and cardiovascular and all-cause mortality in the community-based elderly population: results from the Specific Health Check and Guidance Program in Japan.社区老年人群中肾功能与心血管疾病及全因死亡率的关联:来自日本特定健康检查与指导项目的结果
Clin Exp Nephrol. 2018 Apr;22(2):346-352. doi: 10.1007/s10157-017-1455-0. Epub 2017 Jul 25.
8
HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction.高密度脂蛋白胆固醇与肾功能不全患者的较低死亡率无关。
J Am Soc Nephrol. 2014 May;25(5):1073-82. doi: 10.1681/ASN.2013050482. Epub 2014 Mar 7.
9
Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study.估算肾小球滤过率和白蛋白尿作为高心血管风险患者结局的预测指标:一项队列研究。
Ann Intern Med. 2011 Mar 1;154(5):310-8. doi: 10.7326/0003-4819-154-5-201103010-00005.
10
The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD.烟酸缓释剂对 CKD 患者矿物质代谢标志物的影响。
Clin J Am Soc Nephrol. 2018 Jan 6;13(1):36-44. doi: 10.2215/CJN.05440517. Epub 2017 Dec 5.

引用本文的文献

1
Antioxidative Function of Zinc and Its Protection Against the Onset and Progression of Kidney Disease Due to Cadmium.锌的抗氧化功能及其对镉所致肾脏疾病发生和进展的保护作用。
Biomolecules. 2025 Jan 27;15(2):183. doi: 10.3390/biom15020183.

本文引用的文献

1
Sodium, potassium intake, and all-cause mortality: confusion and new findings.钠、钾摄入量与全因死亡率:困惑与新发现。
BMC Public Health. 2024 Jan 15;24(1):180. doi: 10.1186/s12889-023-17582-8.
2
Association between iron status markers and kidney outcome in patients with chronic kidney disease.慢性肾脏病患者铁状态标志物与肾脏结局的关系。
Sci Rep. 2023 Oct 25;13(1):18278. doi: 10.1038/s41598-023-45580-8.
3
The Independent Association of Plasma and Red Blood Cell Zinc Concentrations with Long-Term Outcomes of Hospitalized Patients.
血浆和红细胞锌浓度与住院患者长期预后的独立关联。
Curr Dev Nutr. 2023 Mar 2;7(4):100062. doi: 10.1016/j.cdnut.2023.100062. eCollection 2023 Apr.
4
Increased Serum Sodium at Acute Kidney Injury Onset Predicts In-Hospital Death.急性肾损伤起病时血清钠升高预示住院死亡。
J Clin Med Res. 2023 Feb;15(2):90-98. doi: 10.14740/jocmr4845. Epub 2023 Feb 28.
5
Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies.铜稳态与铜诱导的细胞死亡在心血管疾病发病机制中的作用及治疗策略。
Cell Death Dis. 2023 Feb 11;14(2):105. doi: 10.1038/s41419-023-05639-w.
6
Associations of Dietary Zinc-Vitamin B6 Ratio with All-Cause Mortality and Cardiovascular Disease Mortality Based on National Health and Nutrition Examination Survey 1999-2016.基于 1999-2016 年全国健康与营养调查的膳食锌-维生素 B6 比值与全因死亡率和心血管疾病死亡率的关联。
Nutrients. 2023 Jan 13;15(2):420. doi: 10.3390/nu15020420.
7
Dietary Zinc Intake and All-Cause and Cardiovascular Mortality in Korean Middle-Aged and Older Adults.膳食锌摄入量与韩国中老年人群全因和心血管死亡率的关系。
Nutrients. 2023 Jan 11;15(2):358. doi: 10.3390/nu15020358.
8
Benefits and risks of essential trace elements in chronic kidney disease: a narrative review.慢性肾脏病中必需微量元素的益处与风险:一项叙述性综述
Ann Transl Med. 2022 Dec;10(24):1400. doi: 10.21037/atm-22-5969.
9
Micronutrient deficiency risk in long-term enterally fed patients: A systematic review.长期接受肠内营养患者的微量营养素缺乏风险:一项系统评价。
Clin Nutr ESPEN. 2022 Dec;52:395-420. doi: 10.1016/j.clnesp.2022.09.022. Epub 2022 Sep 25.
10
Antioxidant Supplementation in Cardiovascular Prevention: New Challenges in the Face of New Evidence.心血管疾病预防中的抗氧化剂补充:面对新证据的新挑战
J Am Coll Cardiol. 2022 Dec 13;80(24):2286-2288. doi: 10.1016/j.jacc.2022.10.011.